Latest Islet cell transplantation Stories
First Ever Person with Type 1 Diabetes Receives Experimental Encapsulated Human Stem Cell-Derived Beta Cell Replacement Therapy NEW YORK, Oct.
NewYork-Presbyterian/Columbia University Medical Center, a national leader in diabetes care, is first in NY metro area to offer new procedure New York, NY (PRWEB)
Allegheny Health Network today announced that Massimo Trucco, MD, one of the world’s foremost physician-scientists with expertise in diabetes and immunogenetics, has been recruited to lead a
NEW YORK, April 24, 2014 /PRNewswire-USNewswire/ -- Building on the momentum and stellar reputation of eight successful years, the 9(th) annual D.R.E.a.M.S.
London, Ontario-based Sernova Corp., is developing a better way to treat the disease involving the replacement of lost pancreatic islets, whose function is to read blood sugar levels and release
MIAMI, Fla., Jan.
Pancreatic islet transplantation is a promising therapy for treating type 1 diabetes, but the majority of transplanted cells die soon after they are transplanted.
More than 260,000 Americans are alive today thanks to transplant operations that have replaced their failing kidneys, hearts, lungs or livers with healthy organs donated by volunteers or accident victims.
This week NewYork-Presbyterian/Weill Cornell Medical Center and The Rogosin Institute celebrate the 50th anniversary of their world-renowned transplant program. New
- Growing in low tufty patches.